Overall Status

Completed (13)

Recruiting (7)

Terminated (3)

Not yet recruiting (2)

Unknown status (2)

Withdrawn (1)

Phase

phase 1/phase 2 (5)

phase 2 (5)

phase 1 (4)

n/a (3)

phase 3 (2)

phase 2/phase 3 (1)

Collaborator

Coventry University (1)

FDA Office of Orphan Products Development (1)

Live Like Bella Pediatric Cancer Research (1)

National Cancer Institute (NCI) (1)

National Health Service, United Kingdom (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institutes of Health (NIH) (1)

University of Manchester (1)

University of Sheffield (1)

Study Documents

Individual Participant Data Set (1)

Manual of Procedures (1)

Study Forms (1)

Study Protocol (1)

Intervention Type

drug (14)

other (6)

procedure (6)

biological (4)

device (4)

radiation (2)

genetic (1)

Funder Type

Other (20)

NIH (5)

Industry (3)

Study Type

Interventional (20)

Observational (7)

Observational [Patient Registry] (1)

severe combined immunodeficiency

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

T-Cell Immune Deficiency Diseases, Severe Combined Immunodeficiency Trial in Atlanta (Busulfan, Fludarabine and ATG)

Completed

T-Cell Immune Deficiency Diseases
Severe Combined Immunodeficiency

Busulfan, Fludarabine and ATG

Atlanta, Georgia

Children's Healthcare of Atlanta

Jun 29, 2009

Severe Combined Immunodeficiency Trial in Memphis (procedure, drug, device)

Completed

Severe Combined Immunodeficiency

Stem cell transplant
+2 more

Memphis, Tennessee

St. Jude Children's Research Hospital

May 19, 2009

Severe Combined Immunodeficieny Disease Due to Adenosine

Completed

Severe Combined Immunodeficiency

ADA PBSC
+2 more

Bethesda, Maryland

National Human Genome Research Institute (NHGRI)

Mar 3, 2008